|Name of Journal||World Journal of Clinical Oncology|
|Title Abbreviation||World J Clin Oncol|
World Journal of Clinical Oncology (WJCO, World J Clin Oncol) is a high-quality, online, open-access, single-blind peer-reviewed journal published by the Baishideng Publishing Group (BPG). WJCO accepts both solicited and unsolicited manuscripts. Articles published in WJCO are high-quality, basic and clinical, influential research articles by established academic authors as well as new researchers. The paramount objective of WJCO is to showcase and promote distinguished research in the field of oncology, to help advance development of this field. The types of articles published in WJCO include Editorial, Opinion Review, Frontier, Review, Minireview, Basic Study, Clinical Research, Systematic Review, Meta-analysis, Evidence-based Medicine, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report.
The primary aim of WJCO is to provide scholars and readers from various fields of oncology with a platform to publish high-quality basic and clinical research articles and communicate their research findings online. In order to ensure the quality, timeliness, fairness, and transparency of publication, WJCO has implemented a variety of measures as follows:
First, authors must prepare their articles according to the appropriate international publication recommendations, including the STROBE Statement, CONSORT 2010 Statement, PRISMA 2009 Checklist, and CARE Checklist – 2016: Information for writing a case report.
Second, articles published in WJCO must undergo rigorous cross-international peer review. WJCO peer reviewers come from different countries, chosen independently by artificial intelligence technique or our editorial office, and not by the authors, to ensure fairness and integrity of the peer review.
Third, designation of co-first authors and/or co-corresponding authors is not permitted.
Fourth, WJCO accepts a manuscript for publication based on its novelty, innovativeness, data accuracy, image reliability, clear language expression, and ethical requirements.
Of note, peer reviewers are advised to complete their peer review within 7 days, providing a comprehensive evaluation of the scientific and linguistic quality of the manuscript.
Fifth, BPG adopts a 7-day publishing management policy. This means that each step of the publishing process, including manuscript preview, peer review, manuscript revision by authors, final acceptance, language editing, and production, and release, must be completed within 7 days.
Finally, the peer review report, author’s response to the peer review report, biostatistics review certificate, copyright license agreement, institutional ethics committee approval document, informed consent document(s), conflict-of-interest statement, CrossCheck detection report, authors’ personal ORCID numbers, funding information, language editing certificate, and other relevant documents will be published online along with the article to allow for an open and transparent publishing process.
|Scope||WJCO mainly publishes articles reporting research results obtained in the field of oncology and covering a wide range of topics, including art of oncology, biology of neoplasia, breast cancer, cancer prevention and control, cancer-related complications, diagnosis in oncology, gastrointestinal cancer, genetic testing for cancer, gynecologic cancer, head and neck cancer, hematologic malignancy, lung cancer, melanoma, molecular oncology, neurooncology, palliative and supportive care, pediatric oncology, surgical oncology, translational oncology, and urologic oncology.|
|Open Access||Open access|
|Indexing/Abstracting||The WJCO is now abstracted and indexed in PubMed, PubMed Central, Emerging Sources Citation Index (Web of Science), Reference Citation Analysis, China Science and Technology Journal Database, and Superstar Journals Database.|
|Journal Metrics||The 2023 Edition of Journal Citation Reports® cites the 2022 impact factor (IF) for WJCO as 2.8; IF without journal self cites: 2.8; 5-year IF: 3.0; Journal Citation Indicator: 0.36.|
|Article Processing Charge||Article processing charge|
|Editors-in-Chief||Jian-Hua Mao, Hiten RH Patel, Stephen Safe, Ken H Young|
|Article Reprints||Article reprints|
|Help Desk||Help desk|
|Special Statement||Special statement|
|Copyright ©||© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA|
|Contact Us||Contact us|